Two-Year Randomized Controlled Prospective Trial Converting Treatment of Stable Renal Transplant Recipients With Cutaneous Invasive Squamous Cell Carcinomas to Sirolimus - Concepedia

Concepedia

Publication | Closed Access

Two-Year Randomized Controlled Prospective Trial Converting Treatment of Stable Renal Transplant Recipients With Cutaneous Invasive Squamous Cell Carcinomas to Sirolimus

156

Citations

28

References

2013

Year

Judith M. Hoogendijk-van den Akker, Paul Harden, Andries J. Hoitsma, Charlotte M. Proby, Ron Wolterbeek, Jan Nico Bouwes Bavinck, Johan W. de Fijter

Journal of Clinical Oncology

Abstract

Conversion to sirolimus-based immunosuppression failed to show a benefit in terms of SCC-free survival at 2 years.

References

	Year	Citations

Page 1